跳至主要内容
临床试验/ISRCTN15978506
ISRCTN15978506已完成未知

Randomized clinical trial evaluating the effect on many molecular markers well established as atherosclerosis/cardiovascular risk factors of moderate different alcoholic beverages consumption on healthy subjects.

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)0 个研究点目标入组 42 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

2022 Results article in https://doi.org/10.1016/j.clnesp.2022.10.014 (added 05/12/2022)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged over 18 years
  • 2. Able to drink alcohol
  • 3. Able to abstain from alcohol for 1 week

排除标准

  • 1. Established cardiovascular disease, defined as documented atherosclerosis, previous cardiovascular event, myocardial revascularization, heart failure
  • 2. Chronic use of corticosteroids, non-anti-inflammatory steroidal drugs (NSAIDs), statins, oral hypoglycemic agents, insulins, anticoagulants or antiplatelet agents
  • 3. Inability to sign the free and informed consent form
  • 4. History of alcoholism or inability to remain abstinent for the period established in the study
  • 5. Refusal to drink alcohol for the period established
  • 6. Pregnancy

研究者

发起方
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

相似试验

Comparing the effect of moderate daily consumption... | 临床试验